Clinical PCR Market

Global Clinical PCR Market Size, Trends & Analysis - Forecasts to 2027 By Type (Standard/Conventional PCR, Real Time PCR), By Indication (Infectious Disease, Cancer, Genetic Disorder), By End-User (Hospitals & Clinics, Diagnostic Centers, Pharmaceutical & Biotechnology Companies), By Region (North America, Asia Pacific, Central & South America, Europe, and the Middle East & Africa), End-User Landscape Analysis, Company Market Share Analysis, and Competitor Analysis

Category Healthcare
Format
  • ms word
  • ms excel
  • ms ppt
  • pdf
This report was recently updated on May 9 2022 with the latest and most recent market numbers

Global Clinical PCR Market Size

The Global Clinical PCR Market is projected to grow from USD 8.41 billion in 2022 to USD 11.24 billion at a CAGR value of 6.8% from 2022 to 2027.

The diverse range of applications for polymerase chain reaction diagnostics has been one of the major drivers of the clinical PCR market. Polymerase chain reaction tests have been applied in applications such as sequencing in genomics, cloning applications, detection of mutations, forensics, and paternity testing applications, among others.

The growing number of everyday applications of PCR in clinical and forensic testing will further enhance the growth of the clinical PCR market.  

Polymerase chain reaction diagnostic tests are much faster than conventional culturing-based tests. For example, PCR diagnostic tests are being increasingly employed in diagnosing bacterium in samples with low bacterium populations. PCR diagnostic tests are capable of detecting extra pulmonary species that might be missed in smear and culture tests and can be used as screening tests for such smear and culture tests.

The ability of PCR diagnostic tests to effectively demonstrate the presence of the target substance in low concentration samples is of vital importance. The food and beverages industry has been increasingly adopting PCR-based diagnostic tests to identify spoilage and authenticate the authenticity of food ingredients. The meat industry has been susceptible to the use of adulterants and low-quality meat. In the clinical PCR market, the application of PCR for meat species identification is likely to create attractive potential for growth.

Advancements in polymerase chain reaction testing methods have been instrumental in the growing popularity of PCR diagnostic tests. The development of the novel digital droplet polymerase chain reaction (ddPCR) is expected to have a positive impact on the growing adoption of clinical PCR diagnostic tests.

ddPCR has applications in various fields such as clinical testing, animal and plant diagnostics, and environmental studies. The cost-effectiveness, absolute quantification, and improved signal-to-noise ratio of ddPCR are also expected to increase the availability of clinical PCR in any research laboratory. The clinical PCR market is expected to see remarkable growth during the forecast period as research institutions look to increase the adoption of PCR techniques.

The market is expected to be hampered by the availability of alternative cheaper diagnostic tests, the need for skilled professionals, the high cost of devices, and the limitations such as false positives and the need for supporting diagnosis to confirm the results.

PCR devices cost upwards of USD 55,000 for a single device and can reach upwards of USD 120,000 depending on the company and features. The need for other consumables and skilled professionals will hamper the demand for PCR tests.

global clinical pcr market

COVID-19 Impact on Global Clinical PCR Market

The COVID-19 pandemic has seen the demand for RT-PCR tests grow exponentially. RT-PCR tests allowed for rapid testing of the population with high precision and resulted in these tests becoming the gold standard for conducting COVID-19 tests.

Mandatory RT-PCR test results for travel and movement led to further growth of the clinical PCR market. The high demand for PCR tests is expected to fall as COVID restrictions are eased and vaccination rates increase. The application of PCR tests in various other applications combined with the widespread adoption to combat COVID will see the market grow moderately during the forecast period.

Ukraine-Russia War Impact on Pharmaceutical Industry

The conflict between Russia and Ukraine will have a significant impact on the demand for PCR tests in both countries. The presence of Russian hostiles in Ukraine has hampered the ability of Ukrainian diagnostic laboratories to carry out PCR tests for COVID-19 tests. It is estimated that only 2.5 % to 3% of the laboratories capable of providing PCR tests are conducting them. Companies across the globe are voluntarily restricting trade activities with Russia which will hamper the import of necessary consumables for conducting PCR tests in the country.

Global Clinical PCR Market: By Type

The real-time PCR segment is expected to be the largest clinical PCR market segment based on the type. Studies between conventional PCR tests and real-time PCR tests have shown that real-time polymerase chain reactions hold significant advantages over conventional polymerase chain reactions.

RT-PCR tests are faster, less labor-intensive, and have a lower chance of contamination than their conventional counterparts which has led to their rapid adoption.

The real-time PCR segment is expected to be the fastest-growing segment in the market. The growing demand for RT-PCR tests for COVID tests has led to the rapid growth of the RT-PCR market.

Global Clinical PCR Market: By Indication

The genetic disorder segment is expected to be the most prominent market segment based on the indication. Clinical PCR tests have been long utilized for genomic applications such as detection mutations and genotyping, among others. The adoption of PCR tests for paternity tests and the growing demand for PCR for newborn genetic testing have resulted in the domination of the genetic disorder segment.

The infectious disease segment is expected to be the fastest-growing segment in the clinical PCR market, based on the indication. The growing demand for PCR tests in COVID-19 tests and vaccine development has led to the rapid growth of the infectious diseases segment.

Global Clinical PCR Market: By End-User

The diagnostic centers segment is the largest market segment, based on the end-users. The increased demand for PCR tests for COVID-19 tests has led to the rapid adoption of PCR tests by many diagnostic laboratories. Hospitals have found it cheaper to outsource testing to external laboratories than to conduct in-house testing which has led to the rapid growth of the diagnostic centers segment.

The hospitals & clinics segment is expected to hold the second-largest share of the market, based on end-users. Growing demand for PCR tests for admitting patients and growing investment in hospital and clinical laboratories are the major drivers of the hospital and clinics segment.

asia pacific clinical pcr market

Global Clinical PCR Market: By Region

North America (the United States, Canada, and Mexico) will dominate the clinical PCR market from 2022 to 2027. Favorable government regulations during the pandemic, increased investment in PCR test kits and reagents, and greater investment in research and development in the region have led to the domination of the North American region in the clinical PCR market.

The United States is expected to have the lion's share in the North American Clinical PCR market. This is attributed to the greater adoption of PCR tests for COVID-19 tests, faster approval systems for COVID-19 testing kits in the region, and a large number of major pharmaceutical and biotechnology players present in the country.

However, the Asia-Pacific region is expected to be the fastest-growing region in the clinical PCR market during the forecast period. The rapid growth of the pharmaceutical manufacturing industry in the region, the growing investment in healthcare infrastructure, and the growing adoption of PCR tests in the region are expected to result in the rapid growth of the clinical PCR market in the APAC region.

China is expected to hold the largest share in the Asia Pacific Clinical PCR market. The large population of the country, proactive adoption of PCR tests to meet the demand for PCR tests to combat the spread of COVID-19, and unmet demand in the country has been responsible for the country’s string clinical PCR market.

Global Clinical PCR Market Share and Competitor Analysis

Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, bioMérieux SA, Laboratory Corporation of America, Quest Diagnostics, Hologic, Inc., Abbott, Becton, Dickinson and Company (BD), Thermo Fisher Scientific Inc., BioFire Defense, LLC, Co-Diagnostics, Inc., PCR Biosystems, PCR-Dx, Curiosity Diagnostic, Genome Diagnostics Pvt. Ltd., Molbio Diagnostics Pvt. Ltd., 1drop Inc., Exact Sciences Laboratories, LumiraDx UK Ltd., and Sherlock BioSciences, Inc., among others, are some of the key players in the clinical PCR market.

Please note: This is not an exhaustive list of companies profiled in the report.

Chapter 1   Research Methodology

1.1    Research Assumptions

1.2    Research Methodology

1.2.1    Estimates and Forecast Timeline

1.3    Information Procurement

1.3.1    Purchased Database

1.3.2    GME’s Internal Database

1.3.3    Primary Research

1.3.4    Secondary Sources & Third-Party Perspectives

            1.3.4.1    Company Information Sources: Annual Reports, Investor Presentation, Press Release, SEC Filling, Company Blogs & Website

            1.3.4.2    Secondary Data Sources: World Health Organization, USFDA, IFPMA, American Association of Pharmaceutical Scientists, American Society of Health Systems, and FAPA, among others

1.4    Information or Data Analysis

1.4.1    Data Analysis Models

1.5    Market Formulation & Data Visualization

1.6    Data Validation & Publishing

1.7    Market Model

1.7.1    Model Details

            1.7.1.1   Top-Down Approach

            1.7.1.2   Bottom-Up Approach

1.8    Market Segmentation & Scope

1.9    Market Definition

Chapter 2   Executive Summary

2.1.    Global Market Outlook

2.2     Type Outlook

2.3     Indication Outlook

2.4     End-User Outlook

2.5     Regional Outlook

Chapter 3   Global Clinical PCR Market Trend Analysis

3.1.    Market Introduction

3.2     Penetration & Growth Prospect Mapping

3.3     Impact of COVID-19 on the Clinical PCR Market

3.4     Metric Data on Cash Transactions

3.5     Market Driver Analysis

3.5.1   Market Driver Analysis

3.5.2   Market Restraint Analysis

3.5.3   Industry Challenges

3.5.4   Industry Opportunities

3.6     Porter’s Five Analysis

3.6.1   Supplier Power

3.6.2   Buyer Power

3.6.3   Substitution Threat

3.6.4   Threat from New Entrant

3.7     Market Entry Strategies

Chapter 4   Clinical PCR Market: Type Trend Analysis

4.1    Type: Historic Data vs. Forecast Data Analysis, 2021 vs. 2027

4.2    Standard/Conventional PCR

4.2.1    Market Estimates & Forecast Analysis of Standard/Conventional PCR Segment, By Region, 2019-2027 (USD Billion)

4.3    Real Time PCR

4.3.1    Market Estimates & Forecast Analysis of Real Time PCR Segment, By Region, 2019-2027 (USD Billion)

4.4    Others

4.4.1    Market Estimates & Forecast Analysis of Others Segment, By Region, 2019-2027 (USD Billion)

Chapter 5   Clinical PCR Market: Indication Trend Analysis

5.1    Indication: Historic Data vs. Forecast Data Analysis, 2021 vs. 2027

5.2    Infectious Disease

5.2.1    Market Estimates & Forecast Analysis of Infectious Disease Segment, By Region, 2019-2027 (USD Billion)

5.3    Cancer

5.3.1    Market Estimates & Forecast Analysis of Cancer Segment, By Region, 2019-2027 (USD Billion)

5.4    Genetic Disorder

5.4.1    Market Estimates & Forecast Analysis of Genetic Disorder Segment, By Region, 2019-2027 (USD Billion)

5.5    Others

5.5.1    Market Estimates & Forecast Analysis of Genetic Disorder Segment, By Region, 2019-2027 (USD Billion)

Chapter 6   Clinical PCR Market: End-User Trend Analysis

6.1    End-User: Historic Data vs. Forecast Data Analysis, 2021 vs. 2027

6.2    Hospitals & Clinics

6.2.1    Market Estimates & Forecast Analysis of Hospitals & Clinics End-User Segment, By Region, 2019-2027 (USD Billion)

6.3    Diagnostic Centers

6.3.1    Market Estimates & Forecast Analysis of Diagnostic Centers End-User Segment, By Region, 2019-2027 (USD Billion)

6.4    Pharmaceutical & Biotechnology Companies

6.4.1    Market Estimates & Forecast Analysis of Others End-User Segment, By Region, 2019-2027 (USD Billion)

6.5    Others

6.5.1    Market Estimates & Forecast Analysis of Others End-User Segment, By Region, 2019-2027 (USD Billion)

Chapter 7   Clinical PCR Market, By Region

7.1    Regional Outlook

7.2    North America

7.2.1    Market Estimates & Forecast Analysis, By Country 2019-2027 (USD Billion)

7.2.2    Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Billion)

7.2.3    Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Billion)

7.2.4    Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Billion)

7.2.5    U.S.

7.2.5.1    Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Billion)

7.2.5.2    Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Billion)

7.2.5.3    Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Billion)

7.2.6    Canada

7.2.6.1    Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Billion)

7.2.6.2    Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Billion)

7.2.6.3    Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Billion)

7.5.7    Mexico

7.5.5.1    Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Billion)

7.5.5.2    Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Billion)

7.5.5.3    Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Billion)

7.3    Europe

7.3.1    Market Estimates & Forecast Analysis, By Country 2019-2027 (USD Billion)

7.3.2    Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Billion)

7.3.3    Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Billion)

7.3.4    Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Billion)

7.3.5    Germany

7.3.5.1    Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Billion)

7.3.5.2    Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Billion)

7.3.5.3    Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Billion)

7.3.6    UK

7.3.6.1    Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Billion)

7.3.6.2    Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Billion)

7.3.6.3    Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Billion)

7.3.7    France

7.3.7.1    Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Billion)

7.3.7.2    Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Billion)

7.3.7.3    Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Billion)

7.3.8    Russia

7.3.8.1    Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Billion)

7.3.8.2    Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Billion)

7.3.8.3    Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Billion)

7.3.9    Italy

7.3.9.1    Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Billion)

7.3.9.2    Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Billion)

7.3.9.3    Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Billion)

7.3.10    Spain

7.3.10.1    Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Billion)

7.3.10.2    Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Billion)

7.3.10.3    Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Billion)

7.3.11    Rest of Europe

7.3.11.1    Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Billion)

7.3.11.2    Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Billion)

7.3.11.3    Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Billion)

7.4    Asia Pacific

7.4.1    Market Estimates & Forecast Analysis, By Country 2019-2027 (USD Billion)

7.4.2    Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Billion)

7.4.3    Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Billion)

7.4.4    Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Billion)

7.4.5    China

7.4.5.1    Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Billion)

7.4.5.2    Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Billion)

7.4.5.3    Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Billion)

7.4.6    India

7.4.6.1    Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Billion)

7.4.6.2    Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Billion)

7.4.6.3    Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Billion)

7.4.7    Japan

7.4.7.1    Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Billion)

7.4.7.2    Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Billion)

7.4.7.3    Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Billion)

7.4.8    Australia

7.4.8.1    Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Billion)

7.4.8.2    Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Billion)

7.4.8.3    Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Billion)

7.4.9    South Korea

7.4.9.1    Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Billion)

7.4.9.2    Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Billion)

7.4.9.3    Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Billion)

7.3.10    Rest of Asia Pacific

7.3.10.1    Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Billion)

7.3.10.2    Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Billion)

7.3.10.3    Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Billion)

7.5    Central & South America

7.5.1    Market Estimates & Forecast Analysis, By Country 2019-2027 (USD Billion)

7.5.2    Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Billion)

7.5.3    Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Billion)

7.5.4   Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Billion)

7.5.5    Brazil

7.5.5.1    Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Billion)

7.5.5.2    Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Billion)

7.5.5.3    Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Billion)

7.5.6    Rest of Central & South America

7.5.6.1    Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Billion)

7.5.6.2    Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Billion)

7.5.6.3    Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Billion)

7.6    Middle East & Africa

7.6.1    Market Estimates & Forecast Analysis, By Country 2019-2027 (USD Billion)

7.6.2    Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Billion)

7.6.3    Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Billion)

7.6.4    Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Billion)

7.6.5    Saudi Arabia

7.6.5.1    Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Billion)

7.6.5.2    Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Billion)

7.6.5.3   Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Billion)

7.6.6    United Arab Emirates

7.6.6.1    Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Billion)

7.6.6.2    Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Billion)

7.6.6.3    Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Billion)

7.6.7    South Africa

7.6.7.1    Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Billion)

7.6.7.2    Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Billion)

7.6.7.3    Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Billion)

7.5.8    Rest of Middle East & Africa

7.5.8.1    Market Estimates & Forecast Analysis, By Type, 2019-2027 (USD Billion)

7.5.8.2    Market Estimates & Forecast Analysis, By Indication, 2019-2027 (USD Billion)

7.5.8.3    Market Estimates & Forecast Analysis, By End-User, 2019-2027 (USD Billion)

Chapter 8   Competitive Analysis

8.1    Key Global Players, Recent Developments & their Impact on the Industry

8.2    Four Quadrant Competitor Positioning Matrix

8.2.1    Key Innovators

8.2.2    Market Leaders

8.2.3    Emerging Players

8.2.4    Market Challengers

8.3    Vendor Landscape Analysis

8.4    End-User Landscape Analysis

8.5    Company Market Share Analysis, 2021

Chapter 9   Company Profile Analysis

9.1    Thermo Fisher Scientific, Inc. 

9.1.1    Company Overview

9.1.2    Financial Analysis

9.1.3    Strategic Initiatives

9.1.4    Product Benchmarking

9.2     Siemens Healthcare GmbH

9.2.1    Company Overview

9.2.2    Financial Analysis

9.2.3    Strategic Initiatives

9.2.4    Product Benchmarking

9.3     F. Hoffmann-La Roche Ltd. 

9.3.1    Company Overview

9.3.2    Financial Analysis

9.3.3    Strategic Initiatives

9.3.4    Product Benchmarking

9.4    bioMérieux SA

9.4.1    Company Overview

9.4.2    Financial Analysis

9.4.3    Strategic Initiatives

9.4.4    Product Benchmarking

9.5    Laboratory Corporation of America

9.5.1    Company Overview

9.5.2    Financial Analysis

9.5.3    Strategic Initiatives

9.5.4    Product Benchmarking

9.6     Quest Diagnostics

9.6.1    Company Overview

9.6.2    Financial Analysis

9.6.3    Strategic Initiatives

9.6.4    Product Benchmarking

9.7     Hologic, Inc.

9.7.1    Company Overview

9.7.2    Financial Analysis

9.7.3    Strategic Initiatives

9.7.4    Product Benchmarking

9.8    Abbott

9.8.1    Company Overview

9.8.2    Financial Analysis

9.8.3    Strategic Initiatives

9.8.4    Product Benchmarking

9.9     Becton, Dickinson and Company (BD)

9.9.1    Company Overview

9.9.2    Financial Analysis

9.9.3    Strategic Initiatives

9.9.4    Product Benchmarking

9.10   BioFire Defense, LLC

9.10.1    Company Overview

9.10.2    Financial Analysis

9.10.3    Strategic Initiatives

9.10.4    Product Benchmarking

9.11   Other Companies

9.11.1    Company Overview

9.11.2    Financial Analysis

9.11.3    Strategic Initiatives

9.11.4    Product Benchmarking

List of Tables

1 Technological Advancements In Clinical PCR Market

2 Global Clinical PCR Market: Key Market Drivers

3 Global Clinical PCR Market: Key Market Challenges

4 Global Clinical PCR Market: Key Market Opportunities

5 Global Clinical PCR Market: Key Market Restraints

6 Global Clinical PCR Market Estimates & Forecast Analysis, 2019-2027 (USD Billion)

7 Global Clinical PCR Market, By Type, 2019-2027 (USD Billion)

8 Standard/Conventional PCR: Global Clinical PCR Market, By Region, 2019-2027 (USD Billion)

9 Real Time PCR: Global Clinical PCR Market, By Region, 2019-2027 (USD Billion)

10 Others: Global Clinical PCR Market, By Region, 2019-2027 (USD Billion)

11 Global Clinical PCR Market, By Indication, 2019-2027 (USD Billion)

12 Infectious Disease: Global Clinical PCR Market, By Region, 2019-2027 (USD Billion)

13 Cancer: Global Clinical PCR Market, By Region, 2019-2027 (USD Billion)

14 Genetic Disorder: Global Clinical PCR Market, By Region, 2019-2027 (USD Billion)

15 Others: Global Clinical PCR Market, By Region, 2019-2027 (USD Billion)

16 Global Clinical PCR Market, By End-User, 2019-2027 (USD Billion)

17 Hospitals & Clinics: Global Clinical PCR Market, By Region, 2019-2027 (USD Billion)

18 Diagnostic Centers: Global Clinical PCR Market, By Region, 2019-2027 (USD Billion)

19 Pharmaceutical & Biotechnology Companies: Global Clinical PCR Market, By Region, 2019-2027 (USD Billion)

20 Others: Global Clinical PCR Market, By Region, 2019-2027 (USD Billion)

21 Regional Analysis: Global Clinical PCR Market, By Region, 2019-2027 (USD Billion)

22 North America: Clinical PCR Market, By Type, 2019-2027 (USD Billion)

23 North America: Clinical PCR Market, By Indication, 2019-2027 (USD Billion)

24 North America: Clinical PCR Market, By End-User , 2019-2027 (USD Billion)

25 North America: Clinical PCR Market, By Country, 2019-2027 (USD Billion)

26 U.S: Clinical PCR Market, By Type, 2019-2027 (USD Billion)

27 U.S: Clinical PCR Market, By Indication, 2019-2027 (USD Billion)

28 U.S: Clinical PCR Market, By End-User, 2019-2027 (USD Billion)

29 Canada: Clinical PCR Market, By Type, 2019-2027 (USD Billion)

30 Canada: Clinical PCR Market, By Indication, 2019-2027 (USD Billion)

31 Canada: Clinical PCR Market, By End-User, 2019-2027 (USD Billion)

32 Mexico: Clinical PCR Market, By Type, 2019-2027 (USD Billion)

33 Mexico: Clinical PCR Market, By Indication, 2019-2027 (USD Billion)

34 Mexico: Clinical PCR Market, By End-User, 2019-2027 (USD Billion)

35 Europe: Clinical PCR Market, By Type, 2019-2027 (USD Billion)

36 Europe: Clinical PCR Market, By Indication, 2019-2027 (USD Billion)

37 Europe: Clinical PCR Market, By End-User, 2019-2027 (USD Billion)

38 Europe: Clinical PCR Market, By Country, 2019-2027 (USD Billion)

39 Germany: Clinical PCR Market, By Type, 2019-2027 (USD Billion)

40 Germany: Clinical PCR Market, By Indication, 2019-2027 (USD Billion)

41 Germany: Clinical PCR Market, By End-User, 2019-2027 (USD Billion)

42 UK: Clinical PCR Market, By Type, 2019-2027 (USD Billion)

43 UK: Clinical PCR Market, By Indication, 2019-2027 (USD Billion)

44 UK: Clinical PCR Market, By End-User, 2019-2027 (USD Billion)

45 France: Clinical PCR Market, By Type, 2019-2027 (USD Billion)

46 France: Clinical PCR Market, By Indication, 2019-2027 (USD Billion)

47 France: Clinical PCR Market, By End-User, 2019-2027 (USD Billion)

48 Italy: Clinical PCR Market, By Type, 2019-2027 (USD Billion)

49 Italy: Clinical PCR Market, By T Indication Ype, 2019-2027 (USD Billion)

50 Italy: Clinical PCR Market, By End-User, 2019-2027 (USD Billion)

51 Spain: Clinical PCR Market, By Type, 2019-2027 (USD Billion)

52 Spain: Clinical PCR Market, By Indication, 2019-2027 (USD Billion)

53 Spain: Clinical PCR Market, By End-User, 2019-2027 (USD Billion)

54 Rest Of Europe: Clinical PCR Market, By Type, 2019-2027 (USD Billion)

55 Rest Of Europe: Clinical PCR Market, By Indication, 2019-2027 (USD Billion)

56 Rest Of Europe: Clinical PCR Market, By End-User, 2019-2027 (USD Billion)

57 Asia Pacific: Clinical PCR Market, By Type, 2019-2027 (USD Billion)

58 Asia Pacific: Clinical PCR Market, By Indication, 2019-2027 (USD Billion)

59 Asia Pacific: Clinical PCR Market, By End-User, 2019-2027 (USD Billion)

60 Asia Pacific: Clinical PCR Market, By Country, 2019-2027 (USD Billion)

61 China: Clinical PCR Market, By Type, 2019-2027 (USD Billion)

62 China: Clinical PCR Market, By Indication, 2019-2027 (USD Billion)

63 China: Clinical PCR Market, By End-User, 2019-2027 (USD Billion)

64 India: Clinical PCR Market, By Type, 2019-2027 (USD Billion)

65 India: Clinical PCR Market, By Indication, 2019-2027 (USD Billion)

66 India: Clinical PCR Market, By End-User, 2019-2027 (USD Billion)

67 Japan: Clinical PCR Market, By Type, 2019-2027 (USD Billion)

68 Japan: Clinical PCR Market, By Indication, 2019-2027 (USD Billion)

69 Japan: Clinical PCR Market, By End-User, 2019-2027 (USD Billion)

70 South Korea: Clinical PCR Market, By Type, 2019-2027 (USD Billion)

71 South Korea: Clinical PCR Market, By Indication, 2019-2027 (USD Billion)

72 South Korea: Clinical PCR Market, By End-User, 2019-2027 (USD Billion)

73 Middle East & Africa: Clinical PCR Market, By Type, 2019-2027 (USD Billion)

74 Middle East & Africa: Clinical PCR Market, By Indication, 2019-2027 (USD Billion)

75 Middle East & Africa: Clinical PCR Market, By End-User, 2019-2027 (USD Billion)

76 Middle East & Africa: Clinical PCR Market, By Country, 2019-2027 (USD Billion)

77 Saudi Arabia: Clinical PCR Market, By Type, 2019-2027 (USD Billion)

78 Saudi Arabia: Clinical PCR Market, By Indication, 2019-2027 (USD Billion)

79 Saudi Arabia: Clinical PCR Market, By End-User, 2019-2027 (USD Billion)

80 UAE: Clinical PCR Market, By Type, 2019-2027 (USD Billion)

81 UAE: Clinical PCR Market, By Indication, 2019-2027 (USD Billion)

82 UAE: Clinical PCR Market, By End-User, 2019-2027 (USD Billion)

83 Central & South America: Clinical PCR Market, By Type, 2019-2027 (USD Billion)

84 Central & South America: Clinical PCR Market, By Indication, 2019-2027 (USD Billion)

85 Central & South America: Clinical PCR Market, By End-User, 2019-2027 (USD Billion)

86 Central & South America: Clinical PCR Market, By Country, 2019-2027 (USD Billion)

87 Brazil: Clinical PCR Market, By Type, 2019-2027 (USD Billion)

88 Brazil: Clinical PCR Market, By Indication, 2019-2027 (USD Billion)

89 Brazil: Clinical PCR Market, By End-User, 2019-2027 (USD Billion)

90 Thermo Fisher Scientific, Inc.: Products Offered

91 Siemens Healthcare GmbH: Products Offered

92 F. Hoffmann-La Roche Ltd.: Products Offered

93 bioMérieux SA: Products Offered

94 Laboratory Corporation of America: Products Offered

95 Quest Diagnostics: Products Offered

96 Hologic, Inc.: Products Offered

97 Abbott: Products Offered

98 Becton, Dickinson and Company (BD): Products Offered

99 BioFire Defense, LLC: Products Offered

100 Other Companies: Products Offered

List of Figures

1. Global Clinical PCR Market  Segmentation & Research Scope

2. Primary Research Partners and Local Informers

3. Primary Research Process

4. Primary Research Approaches

5. Primary Research Responses

6. Global Clinical PCR Market: Penetration & Growth Prospect Mapping

7. Global Clinical PCR Market: Value Chain Analysis

8. Global Clinical PCR Market  Drivers

9. Global Clinical PCR Market  Restraints

10. Global Clinical PCR Market  Opportunities

11. Global Clinical PCR Market  Challenges

12. Key Clinical PCR Market  Manufacturer Analysis

13. Global Clinical PCR Market: Porter’s Five Forces Analysis

14. PESTLE Analysis & Impact Analysis

15. Thermo Fisher Scientific, Inc.: Company Snapshot

16. Thermo Fisher Scientific, Inc.: Swot Analysis

17. Siemens Healthcare GmbH: Company Snapshot

18. Siemens Healthcare GmbH: Swot Analysis

19. F. Hoffmann-La Roche Ltd.: Company Snapshot

20. F. Hoffmann-La Roche Ltd.: Swot Analysis

21. bioMérieux SA: Company Snapshot

22. bioMérieux SA: Swot Analysis

23. Laboratory Corporation of America: Company Snapshot

24. Laboratory Corporation of America: Swot Analysis

25. Quest Diagnostics: Company Snapshot

26. Quest Diagnostics: Swot Analysis

27. Hologic, Inc.: Company Snapshot

28. Hologic, Inc.: Swot Analysis

29. Abbott: Company Snapshot

30. Abbott: Swot Analysis

31. Becton, Dickinson and Company (BD): Company Snapshot

32. Becton, Dickinson and Company (BD): Swot Analysis

33. BioFire Defense, LLC: Company Snapshot

34. BioFire Defense, LLC: Swot Analysis

35. Other Companies: Company Snapshot

36. Other Companies: Swot Analysis

The Global Clinical PCR Market has been studied from the year 2019 till 2027. However, the CAGR provided in the report is from the year 2022 to 2027. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Clinical PCR Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.

We value your investment and offer free customization with every report to fulfil your exact research needs.
This website is secure and your personal details are safe. Privacy

Frequently Asked Questions

The global clinical PCR market is projected to grow from USD 8.41 billion in 2022 to USD 11.24 billion at a CAGR value of 6.8% from 2022 to 2027.
Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, bioMérieux SA, Laboratory Corporation of America, Quest Diagnostics, Hologic, Inc., Abbott, Becton, Dickinson and Company (BD), Thermo Fisher Scientific Inc., BioFire Defense, LLC, Co-Diagnostics, Inc., PCR Biosystems, PCR-Dx, Curiosity Diagnostic, Genome Diagnostics Pvt. Ltd., Molbio Diagnostics Pvt. Ltd., 1drop Inc., Exact Sciences Laboratories, LumiraDx UK Ltd., and Sherlock BioSciences, Inc., among others, are some of the key players in the clinical PCR market.
The COVID-19 pandemic has seen the demand for RT-PCR tests grow exponentially. RT-PCR tests allowed for rapid testing of the population with high precision and resulted in these tests becoming the gold standard for conducting COVID-19 tests. The high demand for PCR tests is expected to fall as COVID restrictions are eased and vaccination rates increase. The application of PCR tests in various other applications combined with the widespread adoption to combat COVID will see the market grow moderately during the forecast period.
The major drivers of the clinical PCR market are the growing incidence of infectious diseases and genetic disorders among the population, increasing investment in the adoption of PCR tests, advancements in testing techniques such as ddPCR, and the growing applicability of PCR tests.
The conflict between Russia and Ukraine will have a significant impact on the demand for PCR tests in both countries. The presence of Russian hostiles in Ukraine has hampered the ability of Ukrainian diagnostic laboratories to carry out PCR tests for COVID-19 tests. It is estimated that only 2.5 % to 3% of the laboratories capable of providing PCR tests are conducting them. Companies across the globe are voluntarily restricting trade activities with Russia which will hamper the import of necessary consumables for conducting PCR tests in the country.

Tailor made solutions just for you

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

OUR CLIENTS

  • Client of Global Market Estimates - Fedex
  • Client of Global Market Estimates - Samsung
  • Client of Global Market Estimates - Siemens
  • Client of Global Market Estimates - Lonza
  • Client of Global Market Estimates - DuPont
  • Client of Global Market Estimates - Medtronic
  • Client of Global Market Estimates - Toray
  • Client of Global Market Estimates - Signify
  • Client of Global Market Estimates - Teledyne
  • Client of Global Market Estimates - Trelleborg
  • Client of Global Market Estimates - Kikkoman Biochemifa
  • Client of Global Market Estimates - Leoni
  • Client of Global Market Estimates - Molnlycke
  • Client of Global Market Estimates - Spirent
  • Client of Global Market Estimates - Tokyo Electron Limited
  • Client of Global Market Estimates - Aranca
  • Client of Global Market Estimates - Asahi Kasei
  • Client of Global Market Estimates - Chimai
  • Client of Global Market Estimates - Grapsud
  • Client of Global Market Estimates - Horiba
  • Client of Global Market Estimates - Indorama
  • Client of Global Market Estimates - L&T
  • Client of Global Market Estimates - Integralife
  • Client of Global Market Estimates - Synamedia
  • Client of Global Market Estimates - Sorrento Therapeutics
  • Client of Global Market Estimates - Solenis
  • Client of Global Market Estimates - Sartorius